Company performance
Add to research
Current Price
as of Apr 21, 2025$0.46
P/E Ratio
N/A
Market Cap
$74.52M
Description
Add to research
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Metrics
Add to research
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerTNYA
- Price$0.4582+1.82%
Trading Information
- Market cap$74.52M
- Float82.48%
- Average Daily Volume (1m)2,537,197
- Average Daily Volume (3m)3,385,045
- EPS-$1.31
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$111.13M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$107.48M
- EV$73.46M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.43
- Debt/Equity14.66
Documents
Add to research
SEC Filings
Factset Street Account